Proteostasis Therapeutics Inc (NASDAQ:PTI)

2.80
Delayed Data
As of Jul 18
 +0.03 / +1.08%
Today’s Change
1.41
Today|||52-Week Range
8.61
-51.97%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Proteostasis Therapeutics Inc have a median target of 12.50, with a high estimate of 25.00 and a low estimate of 5.00. The median estimate represents a +346.43% increase from the last price of 2.80.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Proteostasis Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.51
Sales
$1.3M
Reporting Date
Aug 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -59.38%
 
 
 
 
 
 
Growthannually 15.06%
 
 
 
 
 

Sales

Growthquarterly 38.87%
 
 
 
 
 
 
Growthannually -0.99%
 
 
 
 
 
Key to the earnings and sales forecast charts.